📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
HOMECOVERAGENXTC › EARNINGS
EARNINGS HUB
News Coverage Earnings Hub Earnings Report Grades
$NXTC
NXTC Earnings: Beat 3/4 · 4 quarters tracked
LAST 30 DAYS
0 articles
AVG GRADE
SENTIMENT
TOTAL VIEWS
0
◈ EARNINGS HUB · 2026-03

NXTC Earnings: Beat, Surprise History & Forecast

3/4 quarters beaten · Last EPS $-1.87 (+12.8%) · AI Grade:
◈ ESEN AI · EARNINGS PREVIEW
NXTC reported EPS of $-1.87 in its most recent quarter (2026-03), beating consensus estimate of $-2.15 by +12.8%. Over the last 4 quarters, the company has beaten estimates 3 times (75% beat rate) with an average surprise of +-9.8%. ESEN AI grade: .
LAST EPS
$-1.87
est $-2.15
LAST SURPRISE
+12.8%
2026-03
BEAT RATE
3/4
beats / quarters
AVG SURPRISE
-9.8%
last 4Q
◆ EPS MOMENTUM
PERIOD
ACTUAL EPS
ESTIMATE
SURPRISE
2026-03-31
$-1.87
$-2.15
+12.8%
2025-12-31
$-0.81
$-2.46
+67.1%
2025-09-30
$-3.22
$-4.06
+20.7%
2025-06-30
$-11.29
$-4.71
-139.8%
◈ RELATED EARNINGS NEWS
SeekingAlpha
2026-07-14
NextCure announces reverse merger with privately held Avere
NEUTRAL
manilatimes.
2026-07-14
NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
NEUTRAL
GlobalNewswi
2026-07-14
NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
NEUTRAL
View all NXTC news →
◈ FREQUENTLY ASKED QUESTIONS
When did $NXTC last report earnings?
NXTC last reported earnings on 2026-03-31, with actual EPS of $-1.87 vs estimate of $-2.15.
Did $NXTC beat earnings estimates?
Yes, NXTC beat consensus EPS by +12.8% in its most recent quarter.
What is $NXTC's earnings beat rate?
NXTC has beaten consensus EPS in 3 of 4 quarters (75%). Average surprise: +-9.8%.
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours. Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice